Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain
- Title
- Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain
- Author
- 김동욱
- Keywords
- Shigella; vaccine; O-antigen polymerase; cross-protection; conserved surface proteins
- Issue Date
- 2018-10
- Publisher
- FRONTIERS MEDIA SA
- Citation
- FRONTIERS IN MICROBIOLOGY, v. 9, Article no. 2609
- Abstract
- Shigella is a highly prevalent bacterium causing acute diarrhea and dysentery in developing countries. Shigella infections are treated with antibiotics but Shigellae are increasingly resistant to these drugs. Vaccination can be a countermeasure against emerging antibiotic-resistant shigellosis. Because of the structural variability in Shigellae O-antigen polysaccharides (Oag), cross-protective Shigella vaccines cannot be derived from single serotype-specific Oag. We created an attenuated Shigella flexneri 2a strain with one rather than multiple Oag units by disrupting the Oag polymerase gene (Delta wzy), which broadened protective immunogenicity by exposing conserved surface proteins. Inactivated Delta wzy mutant cells combined with Escherichia coli double mutant LT(R192G/L211A) as adjuvant, induced potent antibody responses to outer membrane protein PSSP-1, and type III secretion system proteins IpaB and IpaC. Intranasal immunization with the vaccine preparation elicited cross-protective immunity against S. flexneri 2a, S. flexneri 3a, S. flexneri 6, and Shigella sonnei in a mouse pneumonia model. Thus, S. flexneri 2a Delta wzy represents a promising candidate strain for a universal Shigella vaccine.
- URI
- https://www.frontiersin.org/articles/10.3389/fmicb.2018.02609/fullhttps://repository.hanyang.ac.kr/handle/20.500.11754/106167
- ISSN
- 1664-302X
- DOI
- 10.3389/fmicb.2018.02609
- Appears in Collections:
- COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML